HealthyCloud Advances in health and biomedical sciences require that health research is performed timely, efficiently and oriented to high-quality results. To meet this need and to maximise the impact of health resear... (read more)
Published on: March 11, 2021
ELIXIR Luxembourg
ELIXIR-LU, the Luxembourgish node of ELIXIR, the European infrastructure for life science information, focuses on long-term sustainability of tools and data for Translational Medicine.
Translational Medicine data integrate clinical information with molecular and cellular data for a better understanding of diseases.
ELIXIR-LU aims to facilitate long-term access to those research data and to tools for scientists in both academia and industry. This will allow the reuse of previously generated data to address new research questions and dramatically save time and cost.
Projects
ELIXIR-LU is involved in several large EU funded projects.
To know more, please click here.
Support and user training
Workshops and courses on data management, curation, analytics and visualisation. Continuous education of software developers, data managers and researchers.
Services
Repository for high quality Translational Medicine dataIntegration of well-curated clinical and molecular data from cohorts and large consortia. Implementation of standardised electronic data capture, data harmonisation and curation.
High-performance data access and computing servicesSustainable access management according to well-defined criteria, in order to meet the security and accountability requirements of ELIXIR, of the General European data protection regulation (GDPR), and of the research community. Platforms and tools to allow efficient data access and analysis.
Tweets by elixir_lu
Our news
ELIXIR-LU and LCSB contribute to the development of a European Health Data Space
ELIXIR-LU first EKES webinar with PetaGene
In November, ELIXIR-LU and PetaGene shared the first EKES (ELIXIR Knowledge Exchange Scheme) pilot outcome — a webinar on genomic data privacy. This workshop was the basis for future collaboration between Petagene and... (read more)
Published on: December 07, 2020
